Transcutaneous bilirubin level to predict hyperbilirubinemia in preterm neonates

Dewi Rahmawati, Mahendra Tri Arif Sampurna, Risa Etika, Martono Tri Utomo, Arend F Bos, Dewi Rahmawati, Mahendra Tri Arif Sampurna, Risa Etika, Martono Tri Utomo, Arend F Bos

Abstract

Background: Hyperbilirubinemia is common in neonates, with higher prevalence among preterm neonates, which can lead to severe hyperbilirubinemia. Assessment of total serum bilirubin (TSB) and the use of a transcutaneous bilirubinometry (TcB) are existing methods that identify and predict hyperbilirubinemia. This study aimed to determine TcB cut-off values during the first day for preterm neonates to predict hyperbilirubinemia at 48 and 72 hours. Methods: This cohort study was conducted at Dr. Soetomo General Hospital from September 2018 to January 2019 a total of 90 neonates born ≤35 weeks. They were divided into two groups (Group I: 1000-1500 grams; Group II: 1501-2000 grams). The bilirubin levels were measured on the sternum using TcB at the ages of 12, 24, and 72 hours. TSB measurements were taken on the third day or if the TcB level reached phototherapy threshold ± 1.24 mg/dL and if TcB showed abnormal results (Group I: 5.76-8.24 mg/dL; Group II: 8.76-11.24 mg/dL). Hyperbilirubinemia was defined as TSB ≥7 mg/dL for Group I and >10 mg/dL for Group II. Results: In total, 38 Group I neonates and 48 Group II neonates were observed. Almost half of the neonates in Group I (45%) suffered from hyperbilirubinemia at the age of 48 hours, along with 46% of Group II at 72 hours. The best 24-hour-old TcB cut-off values to predict hyperbilirubinemia at 48 hours were calculated to be 4.5 mg/dL for Group I and 5.8 mg/dL for Group II. The determined 24-hour-old TcB value to predict hyperbilirubinemia at 72 hours was 5.15 mg/dL for Group II. Conclusion: TcB values in the early days of life can be used as hyperbilirubinemia predictors on the following days for preterm neonates. Close monitoring should be managed for those with TcB values higher than the calculated cut-off values.

Keywords: hyperbilirubinemia; predict; preterm neonates; transcutaneous bilirubin.

Conflict of interest statement

No competing interests were disclosed.

Copyright: © 2020 Rahmawati D et al.

Figures

Figure 1.. The proportionof hyperbilirubinemia in preterm…
Figure 1.. The proportionof hyperbilirubinemia in preterm neonates.
Figure 2.. Transcutaneous bilirubinometry (TcB) level to…
Figure 2.. Transcutaneous bilirubinometry (TcB) level to predict hyperbilirubinemia at the age of 48 hours.
(a) Receiver operating characteristic (ROC) curve for TcB at the age of 12 hours to predict hyperbilirubinemia at the age of 48 hours for Group I. (b) ROC curve for TcB at the age of 24 hours to predict hyperbilirubinemia at the age of 48 hours for Group I. (c) ROC curve for TcB at the age of 12 hours to predict hyperbilirubinemia at the age of 48 hours for Group II. (d) ROC curve for TcB at the age of 24 hours to predict hyperbilirubinemia at the age of 48 hours for Group II.
Figure 3.. Transcutaneous bilirubinometry (TcB) level to…
Figure 3.. Transcutaneous bilirubinometry (TcB) level to predict hyperbilirubinemia at the age of 72 hours.
(a) Receiver operating characteristic (ROC) curve for TcB at the age of 12 hours to predict hyperbilirubinemia at the age of 72 hours for Group II. (b) ROC curve for TcB at the age of 24 hours to predict hyperbilirubinemia at the age of 72 hours for Group II. (c) ROC curve for TcB at the age of 48 hours to predict hyperbilirubinemia at the age of 72 hours for Group II.

References

    1. Han S, Yu Z, Liu L, et al. : A model for predicting significant hyperbilirubinemia in neonates from China. Pediatrics. 2015;136(4):e896–905. 10.1542/peds.2014-4058
    1. Watchko JF, Maisels MJ: Jaundice in low birthweight infants: Pathobiology and outcome. Arch Dis Child Fetal Neonatal Ed. 2003;88(6):F455–8. 10.1136/fn.88.6.f455
    1. Riskin A, Tamir A, Kugelman A, et al. : Is Visual Assessment of Jaundice Reliable as a Screening Tool to Detect Significant Neonatal Hyperbilirubinemia? J Pediatr. 2008;152(6):782–787.e2. 10.1016/j.jpeds.2007.11.003
    1. Mayer I, Gursoy T, Hayran M, et al. : Value of twelfth hour bilirubin level in predicting significant hyperbilirubinemia in preterm Infants. J Clin Med Res. 2014;6(3):190–6. 10.14740/jocmr1639w
    1. Bansal R, Agarwal AK, Sharma M: Predictive Value of Transcutaneous Bilirubin Levels in Late Preterm Babies. Int J Contemp Med Res. 2016;3(6):1661–3.
    1. El-Beshbishi SN, Shattuck KE, Mohammad AA, et al. : Hyperbilirubinemia and transcutaneous bilirubinometry. Clin Chem. 2009;55(7):1280–7. 10.1373/clinchem.2008.121889
    1. Newman TB, Xiong B, Gonzales VM, et al. : Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2000;154(11):1140–7. 10.1001/archpedi.154.11.1140
    1. Sgro M, Campbell D, Shah V: Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ. 2006;175(6):587–90. 10.1503/cmaj.060328
    1. Sanpavat S, Nuchprayoon I: Transcutaneous Bilirubin in the Pre-term Infants. J Med Assoc Thai. 2007;90(9):1803–8.
    1. Sajjadian N, Shajari H, Saalehi Z, et al. : Transcutaneous Bilirubin Measurement in Preterm Neonates. Acta Med Iran. 2012;50(11):765–70.
    1. Jangaard KA, Curtis H, Goldbloom RB: Estimation of bilirubin using BiliChek TM, a transcutaneous bilirubin measurement device: Effects of gestational age and use of phototherapy. Paediatr Child Heal. 2006;11(2):79–83. 10.1093/pch/11.2.79
    1. Dijk PH, Hulzebos CV: An evidence-based view on hyperbilirubinaemia. Acta Paediatr. 2012;101(464):3–10. 10.1111/j.1651-2227.2011.02544.x
    1. van Imhoff DE, Hulzebos CV, Bos AF, et al. : Transcutaneous bilirubin measurements in preterm infants: Effects of photo-therapy and treatment : The management of hyperbilirubinemia in preterm infants2017;77–90.
    1. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297–316. 10.1542/peds.114.1.297
    1. Taheri PA, Sadeghi M, Sajjadian N: Severe neonatal hyperbilirubinemia leading to exchange transfusion. Med J Islam Repub Iran. 2014;28(1):64.
    1. Nagar G, Vandermeer B, Campbell S, et al. : Reliability of transcutaneous bilirubin devices in preterm infants: A systematic review. Pediatrics. 2013;132(5):871–81. 10.1542/peds.2013-1713
    1. Bhat RY, Kumar PCG: Sixth hour transcutaneous bilirubin predicting significant hyperbilirubinemia in ABO incompatible neonates. World J Pediatr. 2014;10(2):182–5. 10.1007/s12519-013-0421-5
    1. Sampurna MTA, Rahmawati D, Etika R, et al. : STROBE Analysis - TcB and TSB. figshare.Preprint.2020. 10.6084/m9.figshare.11991672.v2
    1. Sampurna MTA, Rahmawati D, Etika R, et al. : Supplemental File - Flow Chart Study of TcB and TSB. figshare.Figure.2020. 10.6084/m9.figshare.12017586.v1
    1. Hulley SB, Cumming SR, Browner WS, et al. : Designing Clinical Research. Fourth Edition. 4th Edition. Wolters Kluwer, Lippincott Williams Wilkins. Philadelphia, PA 19103 USA. LIPPINCOTT WILLIAMS & WILKINS, a WOLTERS KLUWER business;2013.
    1. Kaplan M, Wong R, Sibley E, et al. : Neonatal Jaundice and Liver : Martin’s Neonatal-Perinatal Medicine2011;1443–90.
    1. Doumas BT, Kwok-Cheung PP, Perry BW: Candidate reference method for determination of total bilirubin in serum: Development and Validation. Clin Chem. 1985;31(11):1779–89. 10.1093/clinchem/31.11.1779
    1. Jendrassik L, Grof P: Vereinfachte photometrische Methode zur Bestimmung des Blutbilirubins. Biochem Z. 1938;297:81–9.
    1. Lavanya KR, Jaiswal A, Reddy P, et al. : Predictors of significant jaundice in late preterm infants. Indian Pediatr. 2012;49(9):717–20. 10.1007/s13312-012-0163-9
    1. Cashore WJ: Bilirubin and jaundice in the micropremie. Clin Perinatol. 2000;27(1):171–9. 10.1016/s0095-5108(05)70012-9
    1. Maisels MJ, Watchko JF: Treatment of jaundice in low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2003;88(6):F459–63. 10.1136/fn.88.6.f459
    1. Leite MDGC, Facchini FP: [Evaluation of two guidelines for the management of hyperbilirubinemia in newborn babies weighing less than 2,000 g]. J Pediatr (Rio J). 2004;80(4):285–90. 10.1590/S0021-75572004000500007
    1. Ünsür MT, Ünsür E, Inan N, et al. : The predictive value of first-day bilirubin levels in the early discharge of newborns. Iran J Neonatol. 2015;6(3):1–5.
    1. Grabenhenrich J, Grabenhenrich L, Bührer C, et al. : Transcutaneous bilirubin after phototherapy in term and preterm infants. Pediatrics. 2014;134(5):e1324–9. 10.1542/peds.2014-1677
    1. Bhutani VK, Johnson L, Sivieri E: Predictive Ability of a Predischarge Hour-specific Serum Bilirubin for and Near-term Newborns. Pediatrics. 1999;103(1):6–14. 10.1542/peds.103.1.6
    1. Sampurna MTA, Rahmawati D, Etika R, et al. : Datasheet TcB and TSB - Group 1. figshare.Dataset.2020. 10.6084/m9.figshare.11948490.v1
    1. Sampurna MTA, Rahmawati D, Etika R, et al. : TcB Level and TSB-MTA - Group 2. figshare.Dataset.2020. 10.6084/m9.figshare.11948529.v1

Source: PubMed

3
Abonneren